Amber Severn
Family · Cincinnati, OHNPI 1609017599
Payments from drug & device makers
Across 99 payments — averaging $21.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$759
- AstraZeneca$557
- Amarin Pharma, Inc.$86
- Indivior Inc.$82
- Merck$65
- Medtronic$53
- plus $499 from 20 others
What the payments were for
- Food & beverage$2,102100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $759 |
| AstraZeneca | 11 | $557 |
| Amarin Pharma, Inc. | 4 | $86 |
| Indivior Inc. | 5 | $82 |
| Merck | 4 | $65 |
| Medtronic | 2 | $53 |
| Exact Sciences | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 3 | $41 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $38 |
| Novo Nordisk | 3 | $37 |
| Gilead | 1 | $34 |
| Pfizer | 2 | $34 |
| Xeris Pharmaceuticals, Inc. | 2 | $31 |
| Philips North America LLC | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Abbott | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| GSK | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| Organon | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
| Bayer | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Dexcom, Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,102 in reported general payments places this provider in the 80th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 36 | $47,203 |
| FarxigaDapagliflozin Propanediol | 50 | $45,855 |
| EliquisApixaban | 37 | $23,671 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 28 | $20,008 |
| JanuviaSitagliptin Phosphate | 15 | $13,930 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $11,358 |
| TradjentaLinagliptin | 16 | $10,966 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 15 | $6,404 |
| SymbicortBudesonide/Formoterol Fumarate | 21 | $5,017 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 31 | $4,708 |
| PrometheganPromethazine Hcl | 16 | $4,186 |
| Arnuity ElliptaFluticasone Furoate | 12 | $3,290 |
| Pitavastatin Calcium | 12 | $2,953 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 16 | $2,740 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 75 | $1,866 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $557 | $70,87999 claims |
| Novo NordiskOzempic | $37 | $47,20336 claims |
| PfizerEliquis | $34 | $23,67137 claims |
| GSKTrelegy Ellipta, Arnuity Ellipta | $18 | $14,64926 claims |
| MerckJanuvia | $65 | $13,93015 claims |
| Lilly USA, LLCInsulin Lispro | $15 | $80711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,812 family providers in Ohio.
Other family in Cincinnati
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Lindsey SpencerCincinnati$53K
- Bria BarjucaCincinnati$38K
- Jillian CowanCincinnati$20K
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.